Nicotine Dependence Clinical Trial
Official title:
Behavioral Counseling to Reduce Children's Secondhand Smoke Exposure: A Trial With Maternal Smokers
The goal of this study is to reduce infant and toddlers' secondhand smoke exposure (SHSe) in
a high risk, medically underserved population of maternal smokers. The program is called
"Philadelphia FRESH (Family Rules for Establishing Smokefree Homes)". Participants are
recruited from low-income urban neighborhoods in Philadelphia, Pennsylvania. After
determining study eligibility via telephone screen, all participants complete an in-home
pre-intervention interview that includes self-reported smoking history, current smoking and
exposure patterns, and factors that relate to maternal smoking (such as depressive symptoms,
weight concerns, nicotine dependence,) as well as collection of child urine cotinine (a
biomarker used to detect SHSe).
Participants are randomized after baseline to receive either (a) a moderately intensive (up
to 2 in-home sessions, 8 phone sessions) Behavioral Counseling intervention (BC) delivered
over a 16-week period by counselors trained and supervised by investigators, or (b) an
enhanced Self-Help Control (SHC) that uses brief advice and a detailed self-help manual for
SHSe-reduction and smokingcessation. Post intervention assessments include self-reports of
intervention process, factors associated with intervention effects, and intervention
outcomes that include child urine cotinine (to measure level of SHSe) and participant saliva
cotinine (to verify self-reported smoking quit status). Interviewers and data management
staff remain blind to the treatment assignment. All procedures are implemented after signed
informed consent and were approved by Temple University's Institutional Review Board.
This study represents a community-based behavioral counseling trial designed to reduce
infant and toddlers' secondhand smoke exposure (SHSe) in a high risk, medically underserved
population of African American maternal smokers. The program is called "Philadelphia FRESH
(Family Rules for Establishing Smokefree Homes)". Participants are recruited from low-income
urban neighborhoods in Philadelphia, Pennsylvania via posters on mass transit, newspaper
ads, and referral from pediatricians or community WIC clinics.
Inclusion Criteria:
- mothers who smoke at least 5 cigarettes per day
- have a child under 4 years of age
- report exposing their youngest child to at least 2 of her cigarettes per day. (Child
exposure to a cigarette is defined as a child being in the same room or car when adult
is smoking. Room is defined as 4-walls and a door that closes.)
Exclusion Criteria:
- Diagnosis of a Axis I psychiatric disorder
- pregnant
- not proficient in English.
After determining study eligibility via telephone screen, all participants complete an
in-home baseline interview that includes self-reported smoking history, current smoking and
exposure patterns, and factors that relate to maternal smoking (such as depressive symptoms,
weight concerns, nicotine dependence,) as well as collection of child urine cotinine (a
biomarker used to detect SHSe).
Participants are randomized to receive either a Behavioral Counseling intervention (BC)
delivered over a 16-week period by master's level counselors trained and supervised by
PhD-level investigators, or an enhanced Self-Help Control (SHC) that uses a detailed
self-help manual for SHSe-reduction and smoking cessation. Post intervention assessments at
16 weeks, 3- and 12-month follow-up include self-reports of factors associated with
intervention effects and intervention outcomes that include child urine cotinine (to measure
level of SHSe) and participant saliva cotinine (to verify self-reported smoking quit
status). Interviewers and data management staff remain blind to the treatment assignment.
All procedures are implemented after signed informed consent and were approved by Temple
University's Institutional Review Board.
Behavioral Counseling (BC): Mothers randomized to receive BC complete two in-home, and up to
a 8 proactive telephone counseling sessions within a 16-week period. Mothers also receive
four health education and self-help mailings sent in two week intervals during the first 8
weeks of their participation to supplement the counseling content. (These four mailings are
identical to the self-help materials received by the control group.) The overarching goal of
child SHSe reduction is intended to be achieved through specific BC objectives. These
objectives include facilitation of health education regarding the dangers of SHSe and
smoking, plus the benefits of SHSe-reduction and smoking cessation to maternal and child
health. Additional objectives include (a) building family-level social support to facilitate
home-level smoking behavior change; (b) fostering coping and problem-solving skills to help
participants manage smoking urges as well as general life stressors; (c) providing and
modeling abundant positive reinforcement following SHSe reduction efforts to facilitate
confidence and motivation for more challenging smoking behavior change goals.
Self-Help Control (SHC) group: Participants in SHC group receive an intervention binder with
brief advice by telephone on how to use the manual for SHSe reduction. The binder contains
information identical to the BC group, however, all binder content is included in this
single mailing.
Primary study outcomes include change in (a) maternal-reported child SHSe (reported as
cigarettes exposed per day) obtained via validated timeline follow-back methods; and (b)
baby urine cotinine- a biomarker of SHSe standard in tobacco exposure studies. Secondary
outcomes include (a) change in maternal cigarettes smoked per day and (b) maternal reported
7-day point prevalence abstinence, bioverified by saliva cotinine. Urine and saliva samples
were assayed for cotinine using high performance liquid chromatography-tandem mass
spectrometry as an indicator of exposure to tobacco smoke.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05176418 -
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
|
Early Phase 1 | |
Completed |
NCT04084210 -
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
|
Phase 2 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Withdrawn |
NCT03707600 -
State and Trait Mediated Response to TMS in Substance Use Disorder
|
N/A | |
Recruiting |
NCT03999099 -
Targeting Orexin to Treat Nicotine Dependence
|
Phase 1 | |
Completed |
NCT03847155 -
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
|
N/A | |
Completed |
NCT02840435 -
Study on Sit to Quit Phone Intervention
|
N/A | |
Completed |
NCT02139930 -
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
|
N/A | |
Completed |
NCT01926626 -
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
|
Phase 2 | |
Completed |
NCT01982110 -
A Mindfulness Based Application for Smoking Cessation
|
N/A | |
Completed |
NCT01569490 -
Striving to Quit: First Breath
|
N/A | |
Withdrawn |
NCT01569477 -
Striving to Quit-Wisconsin Tobacco Quit Line
|
N/A | |
Completed |
NCT01685996 -
Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
|
Phase 1/Phase 2 | |
Completed |
NCT01632189 -
The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT00996034 -
Nicotine Vaccination and Nicotinic Receptor Occupancy
|
Phase 2 | |
Completed |
NCT01061528 -
Coping Skills Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT01943994 -
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
|
N/A | |
Withdrawn |
NCT01589081 -
Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect
|
N/A | |
Suspended |
NCT01636336 -
Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects
|
N/A |